ULBP1 and Miyoshi myopathy: (50) observed that mutp53 exerted an inverse effect on the MM1 cell line of MM when mutated and that the administration of the metabolic modulator DCA did not enhance the expression of NK-cell receptor-activating ligands, such as ULBP1, in the p53-mutant cell line.